Pharma News

Bioplastics made from protein sources such as egg albumin and whey may have significant antibacterial properties, scientists, including those of Indian-origin, have found. The findings could eventually lead to their application in plastics used in medical applications such as wound healing dressings, sutures, catheter tubes and drug delivery. The bioplastic materials could also be used for food packaging, researchers said.

[adsense:336x280:8701650588]

Mylan Pharmaceuticals Private Limited, a subsidiary of Mylan N.V.,  has launched generic sofosbuvir 400 mg tablets under the brand name MyHep in India. The product is used for the treatment of chronic hepatitis C,which is a long-lasting infection with the hepatitis C virus. Chronic hepatitis C is a blood-borne infectious disease that affects more than 100 million people in the developing world, including approximately 12 million people in India.

B Jain Pharmaceuticals, the leading manufacturer and distributor of homoeopathic medicines, introduced its latest product - guateria guameri, for bringing down cholesterol. The medicine is effective in treating hyperlipilidemia, which is a risk factor for cardiovascular disease.

Mauna Kea Technologies, inventor of Cellvizio, the multidisciplinary confocal laser endomicroscopy platform, has received regulatory approval from COFEPRIS (Comisión Federal Para la Protección contra Riesgos Sanitarios), the Mexican health authority, for the commercialization of Cellvizio.. Mauna Kea Technologies is now able to implement its marketing strategy with its partner, Endomédica, a company specialized in the fields of interventional endoscopy, gastroenterology, urology and surgery since 1986.

Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, announced today that the PicoWay® picosecond laser received U.S. Food and Drug Administration (FDA) clearance for the treatment of pigmented lesions.

Piramal Imaging is honoured to announce it will provide funding and support, along with other industry partners, for a major clinical study titled, "Imaging Dementia – Evidence for Amyloid Scanning" (IDEAS). The trial is designed to evaluate the impact of positron emission tomography (PET) scanning of beta-amyloid deposits in the diagnosis of Alzheimer’s disease (AD) and Dementia in a defined patient population.

The Chennai based Frontier Lifeline Hospital (FLL) and The Institute for Atherosclerosis Research, Moscow in Russia,  merge for a collaborative research agreement to study the ‘genetic similarities causing heart diseases in Russians & Indians’.

AstraZeneca, a global, innovation-driven biopharmaceutical business,  announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation for the MEK inhibitor selumetinib, for the treatment of uveal melanoma.